scholarly journals Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole

2003 ◽  
Vol 51 (4) ◽  
pp. 1017-1020 ◽  
Author(s):  
A. Cruz
Keyword(s):  
Giardia Lamblia ◽  
In Vitro Susceptibility

scholarly journals Screening for Antimicrobial Activities of Metanollic Extracts of Aloe vera and Hyptis suaveolens against Co-infections of Giardia lamblia and Salmonella among Diarrhoeagenic Children

2019 ◽  
pp. 1-6 ◽  
Author(s):  
Omammegbe Abdulrahman ◽  
Adamu B. Samaila ◽  
S. M. Panda ◽  
Abdullahi Aliyu ◽  
M. R. Sahal
Keyword(s):  
Antibacterial Activity ◽  
Giardia Lamblia ◽  
Aloe Vera ◽  
Antimicrobial Activities ◽  
Inhibitory Effects ◽  
Zone Of Inhibition ◽  
In Vitro Susceptibility ◽  
Methanol Extracts ◽  
Hyptis Suaveolens

The antimicrobial and Phytochemicals activities of methanol extracts obtained from Aloe vera and Hyptis suaveolens plants were investigated individually and combined in an attempt to evaluate their medicinal potentials and efficacies on protozoan; Giardia lamblia and bacteria; Salmonella species as co-infections causing diarrhoea in under five populations in Bauchi State, Nigeria. The phytochemical screening revealed the presence of saponins, tannins, alkaloids, flavonoids, terpenoids, alkaloids, phenols. Antimicrobial activity was determined against Giardia lamblia and Salmonella species; anti-giardial activity, an in-vitro susceptibility assays method was performed and antibacterial activity was carried out by Kirby-Bauer method. The parasites mortality was determined by counting in hemocytometer under a light microscope and the zone of inhibition diameter produced against the bacteria were determined, expressed as mean ±SEM (Standard Error of Mean) and the differences between means were statistically analyzed and compared. The results obtained showed that methanol extracts of Aloe vera and Hyptis suaveolens singly used and in combinations had inhibitory effects on Giardia lamblia and Salmonella species. In all cases, the extractions, plants, concentrations and time were determinant factors for the anti-giardial and antibacterial activity. Anti-giardial activity was best recorded with extracts of Aloe vera which showed anti-giardial activity of (0.002±0.553), and activity was greater in combined Aloe vera and Hyptis suaveolens which showed anti-giardial activity of (0.002±0.679). Also, antibacterial activity of methanol extracts of these plants on Salmonella species, showed higher zone of inhibitions diameter with extracts of Aloe vera (0.895±20.17) and the efficacy becomes higher with the combined Aloe vera and Hyptis suaveolens which zone of inhibitions is (0.423±27.50).

scholarly journals 146. antifungal Susceptibility Patterns of candida Parapsilosis Bloodstream Isolates in the US, 2008–2018

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S203-S203
Author(s):  
Brenda L Tesini ◽  
Meghan Lyman ◽  
Brendan R Jackson ◽  
Anita Gellert ◽  
William Schaffner ◽  
...  
Keyword(s):  
Candida Species ◽  
Regional Variation ◽  
Antifungal Susceptibility ◽  
Bloodstream Infections ◽  
Emerging Infections ◽  
In Vitro Susceptibility ◽  
Fluconazole Resistance ◽  
The Us ◽  
Susceptibility Patterns

Abstract Background Multidrug resistant Candida is an increasing concern. C. parapsilosis in particular has decreased in vitro susceptibility to echinocandins. As a result, fluconazole had been favored for C. parapsilosis treatment. However, there is growing concern about increasing azole resistance among Candida species. We report on antifungal susceptibility patterns of C. parapsilosis in the US from 2008 through 2018. Methods Active, population-based surveillance for candidemia through the Centers for Disease Control and Prevention’s (CDC) Emerging Infections Program was conducted between 2008–2018, eventually encompassing 9 states (GA, MD,OR, TN, NY, CA, CO, MN, NM). Each incident isolate was sent to the CDC for species confirmation and antifungal susceptibility testing (AFST). Frequency of resistance was calculated and stratified by year and state using SAS 9.4 Results Of the 8,704 incident candidemia isolates identified, 1,471 (15%) were C. parapsilosis; the third most common species after C. albicans and C. glabrata. AFST results were available for 1,340 C. parapsilosis isolates. No resistance was detected to caspofungin (MIC50 0.25) or micafungin (MIC50 1.00) with only one (< 1%) isolate resistant to anidulafungin (MIC50 1.00). In contrast, 84 (6.3%) isolates were resistant to fluconazole and another 44 (3.3%) isolates had dose-dependent susceptibility to fluconazole (MIC50 1.00). Fluconazole resistance increased sharply from an average of 4% during 2008–2014 to a peak of 14% in 2016 with a subsequent decline to 6% in 2018 (see figure). Regional variation is also observed with fluconazole resistance ranging from 0% (CO, MN, NM) to 42% (NY) of isolates by site. Conclusion The recent marked increase in fluconazole resistance among C. parapsilosis highlights this pathogen as an emerging drug resistant pathogen of concern and the need for ongoing antifungal resistance surveillance among Candida species. Our data support the empiric use of echinocandins for C. parapsilosis bloodstream infections and underscore the need to obtain AFST prior to fluconazole treatment. Furthermore, regional variation in fluconazole resistance emphasizes the importance of understanding local Candida susceptibility patterns. Disclosures Lee Harrison, MD, GSK (Consultant)Merck (Consultant)Pfizer (Consultant)Sanofi Pasteur (Consultant)

Sign in / Sign up

Export Citation Format

Share Document